Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

美佑恒 - NMPA Drug Approval Details

Approvals/NMPA/Becotatug Vedotin for Injection

Approved

生物制品

Becotatug Vedotin for Injection

乐普生物科技股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Oct 28, 2025
Approval ID: 8oAiHII2Rel
Company: 乐普生物科技股份有限公司
Type: 生物制品

Approval Details

Approval Id: 8oAiHII2Rel
Approval Number: 国药准字S20250057
Generic Name: 注射用维贝柯妥塔单抗
Generic Name En: Becotatug Vedotin for Injection
Trade Name: 美佑恒
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 50mg/瓶
Reg Date: 2025-10-28
Company Name: 乐普生物科技股份有限公司
Company Address: 上海市闵行区苏召路1628号1幢C280室
Production Company Name: 东曜药业有限公司(注射用维贝柯妥塔单抗小分子 l 1-d 1:湖北华世通生物医药科技有限公司)
Production Company Address: 苏州工业园区长阳街120号（注射用维贝柯妥塔单抗小分子L1-D1：湖北天门经济开发区）
Company Detail Path: /organization/lepu-bio-b

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 28, 2025

Approval ID

8oAiHII2Rel

Type

生物制品

Back to NMPA Approvals